Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Int Braz J Urol ; 42(2): 247-52, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27256178

RESUMEN

PURPOSE: The vast majority of urothelial carcinomas infiltrating the bladder are consistente with high-grade tumors that can be easily recognized as malignant in needle prostatic biopsies. In contrast, the histological changes of low-grade urothelial carcinomas in this kind of biopsy have not been studied. MATERIALS AND METHODS: We describe the clinicopathologic features of two patients with low-grade bladder carcinomas infiltrating the prostate. They reported dysuria and hematuria. Both had a slight elevation of the prostate specific antigen and induration of the prostatic lobes. Needle biopsies were performed. At endoscopy bladder tumors were found in both cases. RESULTS: Both biopsies showed nests of basophilic cells and cells with perinuclear clearing and slight atypia infiltrating acini and small prostatic ducts. The stroma exhibited extensive desmoplasia and chronic inflammation. The original diagnosis was basal cell hyperplasia and transitional metaplasia. The bladder tumors also showed low-grade urothelial carcinoma. In one case, the neoplasm infiltrated the lamina propria, and in another, the muscle layer. In both, a transurethral resection was performed for obstructive urinary symptoms. The neoplasms were positive for high molecular weight keratin (34BetaE12) and thrombomodulin. No metastases were found in either of the patients, and one of them has survived for five years. CONCLUSIONS: The diagnosis of low-grade urothelial carcinoma in prostate needle biopsies is difficult and may simulate benign prostate lesions including basal cell hyperplasia and urothelial metaplasia. It is crucial to recognize low-grade urothelial carcinoma in needle biopsies because only an early diagnosis and aggressive treatment can improve the prognosis for these patients.


Asunto(s)
Carcinoma de Células Transicionales/patología , Hiperplasia Prostática/patología , Neoplasias de la Próstata/patología , Neoplasias de la Próstata/secundario , Neoplasias de la Vejiga Urinaria/patología , Urotelio/patología , Anciano , Biopsia con Aguja , Diagnóstico Diferencial , Humanos , Masculino , Persona de Mediana Edad , Clasificación del Tumor , Próstata/patología , Antígeno Prostático Específico/sangre
3.
Atherosclerosis ; 277: 72-79, 2018 10.
Artículo en Inglés | MEDLINE | ID: mdl-30176567

RESUMEN

BACKGROUND AND AIMS: Research on the biologic activities of HDL, such as cholesterol efflux capacity and HDL composition, has allowed the understanding of the effect of interventions directed to improve cardiovascular risk. Previously, statin therapy has shown conflicting results about its effects on cholesterol efflux capacity of HDL; the underlying mechanisms are unclear but studies with positive effects are associated with an increase of HDL-cholesterol levels. We investigated if 10 weeks of atorvastatin therapy changes HDL efflux capacity and the chemical composition of its subpopulations. METHODS: In a before-after design basis, HDL-cholesterol levels, chemical composition and cholesterol efflux capacity from HDL subpopulations isolated by isophynic ultracentrifugation were assessed in plasma samples from 60 patients with type 2 diabetes mellito (T2DM) at baseline and after 10 weeks of treatment with 20 mg atorvastatin. Cholesterol efflux was measured from human THP-1 cells using large, light HDL2b and small, dense 3c subpopulations as well as total HDL as acceptors. Changes of cholesterol efflux and chemical composition of HDL after treatment were analyzed. Correlations among variables potentially involved in cholesterol efflux were evaluated. RESULTS: A significant decrease of 4% in HDL-cholesterol levels was observed from 47 (42-54) to 45 (39-56) mg/dL, p = 0.02. Cholesterol efflux from total-HDL and HDL2b and 3c subfractions was maintained unchanged after treatment. The total mass of HDL remained unaffected, except for the HDL3a subpopulation accounted for by a significant increase in total protein content. No significant correlations for variables previously known to be associated with cholesterol efflux were found in our study. CONCLUSIONS: Short therapy of 10 weeks with 20 mg of atorvastatin does not modify the cholesterol efflux capacity neither the total mass of HDL2b, HDL3c and total HDL. The discrepancy with previous reports may be due to the selective effects among different classes of statins or differences in the approaches to measure cellular cholesterol efflux.


Asunto(s)
Atorvastatina/uso terapéutico , HDL-Colesterol/sangre , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Dislipidemias/tratamiento farmacológico , Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico , Adulto , Anciano , Atorvastatina/efectos adversos , Biomarcadores/sangre , Estudios Controlados Antes y Después , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/diagnóstico , Dislipidemias/sangre , Dislipidemias/diagnóstico , Femenino , Humanos , Inhibidores de Hidroximetilglutaril-CoA Reductasas/efectos adversos , Macrófagos/metabolismo , Masculino , México , Persona de Mediana Edad , Células THP-1 , Factores de Tiempo , Resultado del Tratamiento , Adulto Joven
4.
Rev Med Inst Mex Seguro Soc ; 55(5): 587-593, 2017.
Artículo en Español | MEDLINE | ID: mdl-29193940

RESUMEN

BACKGROUND: Matricaria Chamomilla L. (Mch), popularly known as chamomile, has been used for centuries as an herbolary remedy due to its broad clinical spectrum. The aim of this study was to evaluate the effect of Mch associated to a vehicle with emollient function in induced atopic dermatitis (AD)-like lesions in a murine model. METHODS: AD was induced with dinitrochlorobenzene on 12 male seven-week old BALB/c mice. Animals were divided in three groups (control, GC; control negative, GCN; and experimental, GE). Liquid petrolatum was applied to the GCN and liquid petrolatum with aqueous extract of Mch at 7% to the GE. Induction and evolution of the lesions were verified by biopsy at 2nd and 6th week. Evaluation of peripheral blood cells to correlate inflammatory cells was made as well at the same weeks. Lesions were clinically evaluated at 2nd, 4th and 6th week. Scratching was monitored according to the observation methodology of Kobayashi et al. RESULTS: Mch aqueous extract associated to a vehicle with emollient function improves atopic dermatitis-like lesions after two weeks.


INTRODUCCIÓN: Matricaria chamomilla L. (Mch), conocida popularmente como manzanilla, ha sido utilizada por cientos de años como remedio herbolario debido a su amplio espectro en cuanto a sus usos clínicos. El objetivo de este trabajo fue evaluar el efecto de Mch asociada a un vehículo con función emoliente como tratamiento de lesiones tipo-dermatitis atópica (DA) en un modelo murino. MÉTODOS: se indujo DA con dinitroclorobenceno a 12 ratones BALB/c macho de siete semanas de edad, divididos en tres grupos (control, GC; control negativo, GCN y; experimental, GE). Se aplicó petrolato líquido al GCN y petrolato líquido con extracto acuoso de Mch al 7% al GE durante cuatro semanas. La inducción y evolución de las lesiones se corroboraron por biopsia a las dos y seis semanas, analizando sangre periférica en búsqueda de células inflamatorias en los mismos tiempos. Las lesiones fueron evaluadas clínicamente a las dos, cuatro y seis semanas. El rascado se evaluó de acuerdo a la metodología de observación de Kobayashi et al. RESULTADOS: el extracto acuoso liofilizado de Mch asociado a un vehículo con función emoliente demostró mejoría del aspecto de las lesiones tipo DA después de dos semanas.


Asunto(s)
Dermatitis Atópica/tratamiento farmacológico , Emolientes/uso terapéutico , Matricaria , Fitoterapia , Extractos Vegetales/uso terapéutico , Animales , Masculino , Ratones , Ratones Endogámicos BALB C , Resultado del Tratamiento
5.
Cir Cir ; 81(5): 459-64, 2013.
Artículo en Español | MEDLINE | ID: mdl-25125067

RESUMEN

Caloric restriction, as a 30 to 60% decrease of ad libitum balanced caloric intake, without malnutrition, is the non-genetic strategy that has consistently extended the average and maximum lifespan of most living beings, and it has been tested from unicellular organisms like yeast Saccharomyces cerevisiae to Rhesus primates. In addition, various genetic and pharmacological caloric restriction models have shown to protect against cancer, cardiovascular and neurodegenerative diseases. Primate studies suggest that this intervention delays the onset of age-related diseases; in humans, it has physiological, biochemical and metabolic effects decreasing diabetes and cardiovascular disease risk factor. Although currently the mechanism by which caloric restriction has its positive effects at the cellular level is unknown, it has been reported to decrease oxidative stress and increase in mitochondrial biogenesis.


La restricción calórica de 30 a 60% de la ingestión calórica ad libitum, equilibrada y sin llegar a la malnutrición, es la estrategia no genética que ha logrado extender el promedio y el periodo máximo de vida de diversos organismos, desde microorganismos unicelulares como la levadura Saccharomyces cerevisiae, hasta primates Rhesus. Modelos genéticos y farmacológicos han mostrado que esta estrategia protege de enfermedades cardiovasculares, neurodegeneración y cáncer. Los estudios efectuados en primates sugieren que la restricción calórica retrasa la aparición de enfermedades asociadas con el envejecimiento, y en humanos implica efectos fisiológicos, bioquímicos y metabólicos que disminuyen los factores de riesgo de enfermedad cardiovascular y diabetes. Aunque en la actualidad se desconocen los mecanismos que generan los efectos positivos, a nivel celular se ha descrito disminución del estrés oxidativo, e incremento de la biogénesis mitocondrial.


Asunto(s)
Restricción Calórica , Prevención Primaria/métodos , Envejecimiento/fisiología , Animales , Composición Corporal , Enfermedades Cardiovasculares/metabolismo , Enfermedades Cardiovasculares/prevención & control , Metabolismo Energético , Humanos , Longevidad , Mitocondrias/metabolismo , Neoplasias/metabolismo , Neoplasias/prevención & control , Enfermedades Neurodegenerativas/metabolismo , Enfermedades Neurodegenerativas/prevención & control , Estrés Oxidativo , Sirtuinas/fisiología , Pérdida de Peso
6.
Int. braz. j. urol ; 42(2): 247-252, Mar.-Apr. 2016. tab, graf
Artículo en Inglés | LILACS | ID: lil-782863

RESUMEN

ABSTRACT Purpose The vast majority of urothelial carcinomas infiltrating the bladder are consistent with high-grade tumors that can be easily recognized as malignant in needle prostatic biopsies. In contrast, the histological changes of low-grade urothelial carcinomas in this kind of biopsy have not been studied. Materials and Methods We describe the clinicopathologic features of two patients with low-grade bladder carcinomas infiltrating the prostate. They reported dysuria and hematuria. Both had a slight elevation of the prostate specific antigen and induration of the prostatic lobes. Needle biopsies were performed. At endoscopy bladder tumors were found in both cases. Results Both biopsies showed nests of basophilic cells and cells with perinuclear clearing and slight atypia infiltrating acini and small prostatic ducts. The stroma exhibited extensive desmoplasia and chronic inflammation. The original diagnosis was basal cell hyperplasia and transitional metaplasia. The bladder tumors also showed low-grade urothelial carcinoma. In one case, the neoplasm infiltrated the lamina propria, and in another, the muscle layer. In both, a transurethral resection was performed for obstructive urinary symptoms. The neoplasms were positive for high molecular weight keratin (34BetaE12) and thrombomodulin. No metastases were found in either of the patients, and one of them has survived for five years. Conclusions The diagnosis of low-grade urothelial carcinoma in prostate needle biopsies is difficult and may simulate benign prostate lesions including basal cell hyperplasia and urothelial metaplasia. It is crucial to recognize low-grade urothelial carcinoma in needle biopsies because only an early diagnosis and aggressive treatment can improve the prognosis for these patients.


Asunto(s)
Humanos , Masculino , Anciano , Hiperplasia Prostática/patología , Neoplasias de la Próstata/patología , Neoplasias de la Próstata/secundario , Neoplasias de la Vejiga Urinaria/patología , Carcinoma de Células Transicionales/patología , Urotelio/patología , Próstata/patología , Biopsia con Aguja , Antígeno Prostático Específico/sangre , Diagnóstico Diferencial , Clasificación del Tumor , Persona de Mediana Edad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA